Cooley Bolsters Life Sciences Partnering & Licensing Practice in London

London – June 14, 2022 – Frances Stocks Allen has joined Cooley as a partner in the firm’s life sciences corporate partnering & licensing practice in London. She arrives from Latham & Watkins, where she was a partner in the firm’s healthcare & life sciences practice in the corporate department in London. Stocks Allen advises leading life sciences companies and industry investors on a range of technology-based commercial matters, including complex licenses, collaborations, acquisitions and divestments.

“Frances is a highly knowledgeable and pragmatic partnering and licensing lawyer, and will be a great asset to our life sciences clients around the world,” said Marya Postner, head of Cooley’s life sciences corporate partnering & licensing practice. “Her experience advising small and mid-size biotech and medical device companies, and regional specialty and multinational pharmaceutical companies, coupled with her general corporate background, makes her a strategic fit for our life sciences partnering team in London and globally.”

Stocks Allen provides sophisticated commercial, transactional and regulatory advice to multinational, European, and US-based companies and investors in the biotech, pharmaceutical and medical device sectors. Her work includes licensing and other complex commercial and intellectual property arrangements, and she has experience advising on UK and EU regulations and data privacy laws, including the General Data Protection Regulation (GDPR).

“As my practice has developed, I have been drawn to Cooley’s robust global life sciences partnering & licensing platform, as well as the firm’s collaborative and supportive culture,” said Stocks Allen. “I am looking forward to working with my new colleagues to guide our biotech, medical device, and pharmaceutical clients through their mission-critical partnering and licensing deals.”

Since 2020, Stocks Allen has been identified by The Legal 500 UK as a rising star in life sciences and healthcare. She received her postgraduate diploma in intellectual property law and practice from the University of Oxford; her MBA in legal services and her legal practice course from BPP University Business School and BPP University Law School, respectively; her graduate diploma in law from the College of Law, London; and her bachelor’s degree in politics, philosophy and economics from the University of Oxford.

Cooley has a dedicated team of more than 40 life sciences corporate partnering and licensing lawyers, including senior team members who are internationally recognized as the best in their field. Cooley brings to bear decades of experience across a range of transaction structures, territories, product stages and technologies, including highly structured transactions with other drivers such as equity, research and development investment, option and stage-acquisition rights, complex financing and tax structuring, and territory and field sharing. Cooley actively represents 1,900+ public and private life sciences company clients worldwide.

Stocks Allen is the latest partner to join Cooley’s London office this year, following the arrival of antitrust & competition partner Caroline Hobson in March.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 1,500 lawyers across 17 offices in the United States, Asia and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may have been generated with the assistance of artificial intelligence (AI) in accordance with our AI Principles, may be considered Attorney Advertising and is subject to our legal notices.